Sandoz Signs Deal To Acquire Evotec Plant For $300M
Swiss pharma company Sandoz Group AG said Wednesday that it has reached a nonbinding deal with its German peer Evotec SE to acquire Just-Evotec Biologics for $300 million....To view the full article, register now.
Already a subscriber? Click here to view full article